Image of a participant being injected with Medicago COVID-19 vaccine candidate

Medicago begins Phase I clinical trials for its COVID-19 vaccine candidate

Medicago, a biopharmaceutical company headquartered in Quebec City, has started Phase I clinical trials for its plant-derived COVID-19 vaccine candidate, administering the first doses...
Image of two people at a table joining though bubbles to show COVID-19: A Catalyst for Change in Government-Industry Partnership

COVID-19: A Catalyst for Change in Government-Industry Partnership

How outsourced pharma healthcare workers are supporting the Office for National Statistics COVID-19 Infection Survey as part of a Government-industry partnership. COVID-19 has seen the...
Image of brain scan to show People with neurological conditions lose out due to COVID-19 delays

People with neurological conditions lose out due to COVID-19 delays

In a recent survey of more than 1600 people with neurological conditions, over 7 in 10 respondents said they had experienced delays to their...
Image of a head with a cloud brain to show Post COVID-19 mental health crisis awaits

Without support for services post COVID-19 mental health crisis awaits

The BMA is warning that we could face a post COVID-19 mental health crisis if urgent support not provided for services. The BMA says...
healthcare professionals in PPE to show Major study into COVID-19 long-term health effects

Major study into COVID-19 long-term health effects

The Health and Social Care Secretary has announced the launch of a major £8.4m research study into the long-term health effects of COVID-19 on...
Image of hands signing a contract to show EC approves Janssen's preventative Ebola vaccine

EC approves Janssen’s preventative Ebola vaccine

Johnson & Johnson has announced that the European Commission (EC) has granted Marketing Authorisation for Janssen’s preventive Ebola vaccine. This marks the first major...
Image of a healthcare professional in PPE with medical equipment and rip to show No clear benefit of HIV antivirals for COVID-19 patients

No clear benefit of HIV antivirals for COVID-19 patients, says study

There is no clear benefit of HIV antivirals for COVID-19 patients, says new study by the Drug Safety Research Unit (DSRU) in Southampton. It...
Image of medicines to show Impact of COVID-19 on cancer research funding

Impact of COVID-19 on cancer research funding

Cancer Research UK has announced that the impact of COVID-19 on its income means it could be forced to cut £150m per year from...
Image of a person in full PPE holding a shield with a health cross on it up to the coronavirus to show New consortium to monitor safety and effectiveness of COVID-19 vaccines

New consortium to monitor safety and effectiveness of COVID-19 vaccines

A new consortium to monitor the safety and effectiveness of COVID-19 vaccines has been formed by the Drug Safety Research Unit (DSRU) in Southampton...
Image of coronavirus and a syringe to show Support for developers of COVID-19 medicinal products

Support for developers of COVID-19 medicinal products

The National Institute for Health and Care Excellence (NICE) and the National Institute for Health Research (NIHR) have launched a guide on clinical evidence...

Latest articles

Logo for Atrial Fibrillation Toolkit: Tackling avoidable strokes to save lives and strain on the NHS

Atrial Fibrillation Toolkit: Tackling avoidable strokes to save lives and strain on the NHS

The AHSN Network of 15 Academic Health Science Networks in England has launched the national ‘Atrial Fibrillation Toolkit’ (www.aftoolkit.co.uk) to address barriers to stroke...
Image of a person presenting data to show Data in NEJM demonstrates efficacy of ofatumumab in patients with relapsing multiple sclerosis

Data in NEJM demonstrates efficacy of ofatumumab in patients with relapsing multiple sclerosis

Novartis announces publication of Phase III ASCLEPIOS trials data in NEJM demonstrating efficacy of the ofatumumab in patients with relapsing multiple sclerosis. Novartis has announced...
Image of business people nurturing plants growing with light bulbs at the top to show Primary care networks and mental health services post COVID-19

Primary care networks and mental health services post COVID-19

Joint working between primary care networks and providers of mental health services must accelerate if the NHS is to help the huge increase in...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Meeting on ipad: COVID-19 pharma workforce

COVID-19: changing the pharma workforce

There’s no denying the COVID-19 has changed the world, but will it have a lasting effect on the pharma workforce? Graham Hawthorn Managing Director, CHASE It is...
Woman holding swab: COVID-19 pandemic

COVID-19: Pharma on the frontline

Pharma stepped up to support the NHS, the country and the World during the COVID-19 pandemic. Pf brings you some examples of pharma on...
Woman with mask on phone: use of electronic prescribing

Accelerated use of electronic prescribing

Deborah Evans, Managing Director of Pharmacy Complete, looks at the instruction to stay at home, GP surgeries closing their doors and consumers rethinking how...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription